Li C - Search Results

1

Discovery of novel SERMs with a ferrocenyl entity based on the oxabicyclo[2.2.1]heptene scaffold and evaluation of their antiproliferative effects in breast cancer cells.

Zheng Y, Wang C, Li C, Qiao J, Zhang F, Huang M, Ren W, Dong C, Huang J, Zhou HB. Zheng Y, et al. Among authors: li c. Org Biomol Chem. 2012 Dec 28;10(48):9689-99. doi: 10.1039/c2ob26226f. Epub 2012 Nov 14. Org Biomol Chem. 2012. PMID: 23149805

2

Design, synthesis and biological evaluation of novel estrogen-derived steroid metal complexes.

Zhang X, Zuo Z, Tang J, Wang K, Wang C, Chen W, Li C, Xu W, Xiong X, Yuntai K, Huang J, Lan X, Zhou HB. Zhang X, et al. Among authors: li c. Bioorg Med Chem Lett. 2013 Jul 1;23(13):3793-7. doi: 10.1016/j.bmcl.2013.04.088. Epub 2013 May 9. Bioorg Med Chem Lett. 2013. PMID: 23726343

3

High-throughput screening assays for estrogen receptor by using coumestrol, a natural fluorescence compound.

Wang C, Li C, Zhou H, Huang J. Wang C, et al. Among authors: li c. J Biomol Screen. 2014 Feb;19(2):253-8. doi: 10.1177/1087057113502673. Epub 2013 Sep 9. J Biomol Screen. 2014. PMID: 24019253

4

Novel Bioactive Hybrid Compound Dual Targeting Estrogen Receptor and Histone Deacetylase for the Treatment of Breast Cancer.

Tang C, Li C, Zhang S, Hu Z, Wu J, Dong C, Huang J, Zhou HB. Tang C, et al. Among authors: li c. J Med Chem. 2015 Jun 11;58(11):4550-72. doi: 10.1021/acs.jmedchem.5b00099. Epub 2015 Jun 2. J Med Chem. 2015. PMID: 25993269

5

Synthesis and structure-activity relationships of novel hybrid ferrocenyl compounds based on a bicyclic core skeleton for breast cancer therapy.

Li C, Tang C, Hu Z, Zhao C, Li C, Zhang S, Dong C, Zhou HB, Huang J. Li C, et al. Bioorg Med Chem. 2016 Jul 1;24(13):3062-3074. doi: 10.1016/j.bmc.2016.05.019. Epub 2016 May 18. Bioorg Med Chem. 2016. PMID: 27240467

6

Novel hybrid conjugates with dual estrogen receptor α degradation and histone deacetylase inhibitory activities for breast cancer therapy.

Zhao C, Tang C, Li C, Ning W, Hu Z, Xin L, Zhou HB, Huang J. Zhao C, et al. Among authors: li c. Bioorg Med Chem. 2021 Jun 15;40:116185. doi: 10.1016/j.bmc.2021.116185. Epub 2021 May 1. Bioorg Med Chem. 2021. PMID: 33965842

7

Selenophenes: Introducing a New Element into the Core of Non-Steroidal Estrogen Receptor Ligands.

Zhang S, Wang Z, Hu Z, Li C, Tang C, Carlson KE, Luo J, Dong C, Katzenellenbogen JA, Huang J, Zhou HB. Zhang S, et al. Among authors: li c. ChemMedChem. 2017 Feb 3;12(3):235-249. doi: 10.1002/cmdc.201600593. Epub 2017 Jan 9. ChemMedChem. 2017. PMID: 27976818 Free PMC article.

8

Sesterterpene MHO7 suppresses breast cancer cells as a novel estrogen receptor degrader.

Zhao Y, Zhao C, Lu J, Wu J, Li C, Hu Z, Tian W, Yang L, Xiang J, Zhou H, Deng Z, Huang J, Hong K. Zhao Y, et al. Among authors: li c. Pharmacol Res. 2019 Aug;146:104294. doi: 10.1016/j.phrs.2019.104294. Epub 2019 Jun 6. Pharmacol Res. 2019. PMID: 31175940

9

Luteolin Reduces BACE1 Expression through NF-κB and through Estrogen Receptor Mediated Pathways in HEK293 and SH-SY5Y Cells.

Zheng N, Yuan P, Li C, Wu J, Huang J. Zheng N, et al. Among authors: li c. J Alzheimers Dis. 2015;45(2):659-71. doi: 10.3233/JAD-142517. J Alzheimers Dis. 2015. PMID: 25589732

10

Anticancer Effects of Honokiol via Mitochondrial Dysfunction Are Strongly Enhanced by the Mitochondria-Targeting Carrier Berberine.

Shi X, Zhang T, Lou H, Song H, Li C, Fan P. Shi X, et al. Among authors: li c. J Med Chem. 2020 Oct 22;63(20):11786-11800. doi: 10.1021/acs.jmedchem.0c00881. Epub 2020 Oct 12. J Med Chem. 2020. PMID: 32996316

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89,890 results

Search Page

Filters